Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today the appointment of Dr. Christian Hunzinger (48) as the new Senior Vice President Project Management, effective from January 15, 2019. Dr. Hunzinger has over 15 years of industry experience in research and development of biopharmaceuticals. He succeeds Dr. Klaus Schoepe who held the same position and will retire in the course of 2019 after working for the company for 14 years.

“We are delighted to welcome Dr. Christian Hunzinger to Rentschler Biopharma. His professional expertise in production and development of biopharmaceutical products and his outstanding experience in the field of project management will significantly contribute to meeting the needs of our clients even better and more sustainably. Together with his project managers, he will intensify and reinforce strategic partnerships with our clients,” explained Dr. Frank Mathias, CEO of Rentschler Biopharma SE.